Your browser doesn't support javascript.
loading
Modern cardiovascular risk management in clinical practice
Volpe, M; Calvieri, C; Alonzo, A; Volpe, M.
Affiliation
  • Volpe, M; University of Rome “La Sapienza”. II Faculty of Medicine. Rome. Italy
  • Calvieri, C; University of Rome “La Sapienza”. II Faculty of Medicine. Rome. Italy
  • Alonzo, A; University of Rome “La Sapienza”. II Faculty of Medicine. Rome. Italy
  • Volpe, M; IRCCS Neuromed–Pozzilli. Irsenia. Italy
Hipertens. riesgo vasc ; 26(6): 275-279, nov. -dic. 2009. ilus
Article in Spanish | IBECS | ID: ibc-87615
Responsible library: ES1.1
Localization: BNCS
RESUMEN
Este artículo revisa la creciente importancia de la morbilidad y mortalidad asociadas a la enfermedad cardiovascular, con especial interés en la implementación de estrategias preventivas que pueden limitar la carga que supone la enfermedad cardiovascular. En concreto, las líneas de actuación serían 1) Realizar una evaluación más completa del riesgo cardiovascular global, especialmente en los pacientes de alto riesgo basal; 2) Alcanzar una reducción del riesgo mediante una intervención terapéutica integral sobre los diferentes componentes del riesgo cardiovascular; 3) Mejorar aquellas estrategias dirigidas a conseguir una reducción del riesgo cardiovascular global a largo plazo, especialmente en los pacientes de alto riesgo, y homogeneizar las recomendaciones de las guías para el manejo del riesgo cardiovascular. La carga sanitaria que supone la enfermedad cardiovascular puede reducirse de forma efectiva mediante la adopción de una mejora en la identificación del paciente riesgo, la estratificación de dicho riesgo y el tratamiento individualizado en las distintas fases del continuo cardiovascular (AU)
ABSTRACT
In this article we address the issue of the continuing growing burden of morbidity and mortality associated to cardiovascular disease, by focusing on how this could be limited by implementing cardiovascular disease prevention strategies. In particular, we propose to 1) performing a more comprehensive evaluation of total CV risk, especially in patients at high baseline risk profile; 2) achieving a risk reduction through a global therapeutic interventionon the different components of CV risk; 3) improving strategies aimed at global CV risk reduction in future years, especially in patients at high risk, and implementing armonization of guidelines for risk management. The burden of CV disease can be effectively reduced by adopting a more comprehensive approach to identification, risk stratification and treatment of individuals along the cardiovascular continuum (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Cardiovascular Disease Database: IBECS Main subject: Cardiovascular Diseases / Biomedical Enhancement Type of study: Etiology study / Practice guideline / Prognostic study / Risk factors Limits: Humans Language: Spanish Journal: Hipertens. riesgo vasc Year: 2009 Document type: Article Institution/Affiliation country: IRCCS Neuromed–Pozzilli/Italy / University of Rome “La Sapienza”/Italy
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Cardiovascular Disease Database: IBECS Main subject: Cardiovascular Diseases / Biomedical Enhancement Type of study: Etiology study / Practice guideline / Prognostic study / Risk factors Limits: Humans Language: Spanish Journal: Hipertens. riesgo vasc Year: 2009 Document type: Article Institution/Affiliation country: IRCCS Neuromed–Pozzilli/Italy / University of Rome “La Sapienza”/Italy
...